Patent · US Active

Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli

US10195262B2 · kind B2 · utility

2Cited by

0References

8Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Michael Wacker · Unterengstringen, CH
Michael Kowarik · Bellinzona, CH
Michael Wetter · Zürich, CH

Key dates

Filing date	Dec 3, 2014
Grant date	Feb 5, 2019
Priority date	—
Expiry date	Dec 3, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are immunogenic compositions and vaccines for the treatment and prevention of Staphylococcus aureus infections. These immunogenic compositions and vaccines comprise combinations of bioconjugates capsular polysaccharides that are N-linked to one or more carrier proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.